PIII PE Ratio & Valuation,Is PIII Overvalued

PIII Relative Valuation

PIII's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PIII is overvalued; if below, it's undervalued.

Historical Valuation

P3 Health Partners Inc (PIII) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.01 is considered Undervalued compared with the five-year average of -5.97. The fair price of P3 Health Partners Inc (PIII) is between 53.73 to 149.70 according to relative valuation methord. Compared to the current price of 5.19 USD , P3 Health Partners Inc is Undervalued By 90.34%.

Relative Value

Fair Zone

53.73-149.70

Current Price：5.19

90.34%

Undervalued

-0.56

-6.28

EV/EBITDA

P3 Health Partners Inc. (PIII) has a current EV/EBITDA of -6.28. The 5-year average EV/EBITDA is -2.49. The thresholds are as follows: Strongly Undervalued below -175.28, Undervalued between -175.28 and -88.88, Fairly Valued between 83.91 and -88.88, Overvalued between 83.91 and 170.31, and Strongly Overvalued above 170.31. The current Forward EV/EBITDA of -6.28 falls within the Historic Trend Line -Fairly Valued range.

-1.98

EV/EBIT

P3 Health Partners Inc. (PIII) has a current EV/EBIT of -1.98. The 5-year average EV/EBIT is -4.01. The thresholds are as follows: Strongly Undervalued below -9.55, Undervalued between -9.55 and -6.78, Fairly Valued between -1.23 and -6.78, Overvalued between -1.23 and 1.54, and Strongly Overvalued above 1.54. The current Forward EV/EBIT of -1.98 falls within the Historic Trend Line -Fairly Valued range.

0.01

P3 Health Partners Inc. (PIII) has a current PS of 0.01. The 5-year average PS is 0.19. The thresholds are as follows: Strongly Undervalued below -0.16, Undervalued between -0.16 and 0.01, Fairly Valued between 0.36 and 0.01, Overvalued between 0.36 and 0.53, and Strongly Overvalued above 0.53. The current Forward PS of 0.01 falls within the Historic Trend Line -Fairly Valued range.

-9.51

P/OCF

P3 Health Partners Inc. (PIII) has a current P/OCF of -9.51. The 5-year average P/OCF is -17.12. The thresholds are as follows: Strongly Undervalued below -114.19, Undervalued between -114.19 and -65.65, Fairly Valued between 31.42 and -65.65, Overvalued between 31.42 and 79.96, and Strongly Overvalued above 79.96. The current Forward P/OCF of -9.51 falls within the Historic Trend Line -Fairly Valued range.

-1.46

P/FCF

P3 Health Partners Inc. (PIII) has a current P/FCF of -1.46. The 5-year average P/FCF is -2.75. The thresholds are as follows: Strongly Undervalued below -15.76, Undervalued between -15.76 and -9.25, Fairly Valued between 3.75 and -9.25, Overvalued between 3.75 and 10.26, and Strongly Overvalued above 10.26. The current Forward P/FCF of -1.46 falls within the Historic Trend Line -Fairly Valued range.

P3 Health Partners Inc (PIII) has a current Price-to-Book (P/B) ratio of 0.34. Compared to its 3-year average P/B ratio of -3.19 , the current P/B ratio is approximately -110.61% higher. Relative to its 5-year average P/B ratio of -2.39, the current P/B ratio is about -114.17% higher. P3 Health Partners Inc (PIII) has a Forward Free Cash Flow (FCF) yield of approximately -571.14%. Compared to its 3-year average FCF yield of -145.52%, the current FCF yield is approximately 292.47% lower. Relative to its 5-year average FCF yield of -98.94% , the current FCF yield is about 477.24% lower.

0.34

P/B

Median3y

-3.19

Median5y

-2.39

-571.14

FCF Yield

Median3y

-145.52

Median5y

-98.94

Competitors Valuation Multiple

The average P/S ratio for PIII's competitors is 0.63, providing a benchmark for relative valuation. P3 Health Partners Inc Corp (PIII) exhibits a P/S ratio of , which is -100% above the industry average. Given its robust revenue growth of -3.93%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of PIII decreased by 53.86% over the past 1 year. The primary factor behind the change was an decrease in Revenue Growth from 388.49M to 373.23M.

The secondary factor is the Margin Expansion, contributed -7.13%to the performance.

Overall, the performance of PIII in the past 1 year is driven by Revenue Growth. Which is more sustainable.

-3.93%

388.49M → 373.23M

Revenue Growth

-7.13%

-12.77 → -11.86

Margin Expansion

-42.80%

-0.22 → -0.13

P/E Change

-53.86%

11.25 → 5.19

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is P3 Health Partners Inc (PIII) currently overvalued or undervalued?

What is P3 Health Partners Inc (PIII) fair value?

PIII's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of P3 Health Partners Inc (PIII) is between 53.73 to 149.70 according to relative valuation methord.

How does PIII's valuation metrics compare to the industry average?

The average P/S ratio for PIII's competitors is 0.63, providing a benchmark for relative valuation. P3 Health Partners Inc Corp (PIII) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of -3.93%, this premium appears unsustainable.

What is the current P/B ratio for P3 Health Partners Inc (PIII) as of Dec 15 2025?

As of Dec 15 2025, P3 Health Partners Inc (PIII) has a P/B ratio of 0.34. This indicates that the market values PIII at 0.34 times its book value.

What is the current FCF Yield for P3 Health Partners Inc (PIII) as of Dec 15 2025?

As of Dec 15 2025, P3 Health Partners Inc (PIII) has a FCF Yield of -571.14%. This means that for every dollar of P3 Health Partners Inc’s market capitalization, the company generates -571.14 cents in free cash flow.

What is the current Forward P/E ratio for P3 Health Partners Inc (PIII) as of Dec 15 2025?

As of Dec 15 2025, P3 Health Partners Inc (PIII) has a Forward P/E ratio of -0.56. This means the market is willing to pay $-0.56 for every dollar of P3 Health Partners Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for P3 Health Partners Inc (PIII) as of Dec 15 2025?

As of Dec 15 2025, P3 Health Partners Inc (PIII) has a Forward P/S ratio of 0.01. This means the market is valuing PIII at $0.01 for every dollar of expected revenue over the next 12 months.

PIII Valuation